These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

90 related articles for article (PubMed ID: 15359933)

  • 1. [PROWESS: description and key results].
    Vallet B
    Ann Fr Anesth Reanim; 2003 Dec; 22 Spec No 1():12-5. PubMed ID: 15359933
    [No Abstract]   [Full Text] [Related]  

  • 2. [The FDA's questions].
    Opal S
    Ann Fr Anesth Reanim; 2003 Dec; 22 Spec No 1():20-2. PubMed ID: 15359935
    [No Abstract]   [Full Text] [Related]  

  • 3. [Surgical patients with severe sepsis: first results of the PROWESS study. Demographic data].
    Montravers P; Blaise M
    Ann Fr Anesth Reanim; 2003 Dec; 22 Spec No 1():38-9. PubMed ID: 15359941
    [No Abstract]   [Full Text] [Related]  

  • 4. Should we be using activated protein C to treat severe sepsis?
    Eve RL; Duffy MR
    Br J Hosp Med (Lond); 2009 Aug; 70(8):484. PubMed ID: 19684544
    [No Abstract]   [Full Text] [Related]  

  • 5. [Activated protein C (the impact of PROWESS trial)].
    Iba T; Kidokoro A
    Nihon Rinsho; 2004 Dec; 62(12):2296-300. PubMed ID: 15597799
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Activated protein C: the cure for sepsis - again?
    Hoth T; Evans TW
    Anaesthesia; 2001 Dec; 56(12):1133-5. PubMed ID: 11736767
    [No Abstract]   [Full Text] [Related]  

  • 7. [PROWESS--milestone in lowering sepsis mortality].
    Reinhart K
    Krankenpfl J; 2002; 40(10-12):315. PubMed ID: 12600016
    [No Abstract]   [Full Text] [Related]  

  • 8. [Clinical approach to the identification of patients suffering from severe sepsis with several organ failures for the administration of drotrecogin alfa (activated): from the PROWESS study to clinical practice].
    Dhainaut JF; Payen DM; Bernardin G; Gérard JL; Martin C; Perrotin D; Regnier B
    Ann Fr Anesth Reanim; 2003 Dec; 22 Spec No 1():53-64. PubMed ID: 15359946
    [No Abstract]   [Full Text] [Related]  

  • 9. [Hemorrhagic risk of drotrecogin alfa (activated) in severe sepsis].
    Perrotin D
    Ann Fr Anesth Reanim; 2003 Dec; 22 Spec No 1():16-9. PubMed ID: 15359934
    [No Abstract]   [Full Text] [Related]  

  • 10. Activated protein C for severe sepsis.
    Ely EW; Bernard GR; Vincent JL
    N Engl J Med; 2002 Sep; 347(13):1035-6. PubMed ID: 12324564
    [No Abstract]   [Full Text] [Related]  

  • 11. Conclusions: drotrecogin alfa (activated)--from bench to practical use at the bedside.
    Maki DG
    Am J Surg; 2002 Dec; 184(6A Suppl):S47-50. PubMed ID: 12521617
    [No Abstract]   [Full Text] [Related]  

  • 12. Drotrecogin alpha (activated).
    Labbos J; Bradsher J; Kirkpatrick P
    Nat Rev Drug Discov; 2003 Jan; 2(1):13-4. PubMed ID: 12521028
    [No Abstract]   [Full Text] [Related]  

  • 13. Sepsis and the role of activated protein C.
    Tazbir J
    Crit Care Nurse; 2004 Dec; 24(6):40-5. PubMed ID: 15646088
    [No Abstract]   [Full Text] [Related]  

  • 14. [Medical-economic evaluation of severe sepsis].
    Guidet B
    Ann Fr Anesth Reanim; 2003 Dec; 22 Spec No 1():28-30. PubMed ID: 15359937
    [No Abstract]   [Full Text] [Related]  

  • 15. Recombinant activated protein C in pediatric sepsis.
    Dalton HJ
    Pediatr Infect Dis J; 2003 Aug; 22(8):743-5. PubMed ID: 12913779
    [No Abstract]   [Full Text] [Related]  

  • 16. [Sepsis therapy -- how effective are the therapy strategies?].
    Brunkhorst F; Reinhart K
    Chirurg; 2008 Sep; 79(9):877-8. PubMed ID: 18942197
    [No Abstract]   [Full Text] [Related]  

  • 17. Breakthrough found in treatment of severe sepsis.
    Clin Resour Manag; 2001 Jul; 2(7):107-9. PubMed ID: 11482248
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Steroids and drotrecogin alfa (activated) for severe sepsis.
    Steingrub JS
    Chest; 2003 Nov; 124(5):2033. PubMed ID: 14605088
    [No Abstract]   [Full Text] [Related]  

  • 19. Recombinant human activated protein C.
    Hughes M
    Int J Antimicrob Agents; 2006 Aug; 28(2):90-4. PubMed ID: 16837170
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Drotrecogin alfa: too early to give it early.
    Smith B
    Emerg Med Australas; 2005 Apr; 17(2):179-80. PubMed ID: 15796737
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.